Nitto Company Information en Tue, 16 Jun 2020 17:00:00 +0800 Nitto Logo Our Response to the Spread of COVID-19 Tue, 16 Jun 2020 17:00:00 +0800 Company News Initiation of multi-regional Phase 2 clinical study of ND-L02-s0201 for idiopathic pulmonary fibrosis (IPF) in Japan Development of ND-L02-s0201 for idiopathic pulmonary fibrosis indication Mon, 02 Mar 2020 15:00:00 +0800 Company News The Nitto ATP Finals charitable activities in support of UNICEF Fri, 14 Feb 2020 09:00:00 +0800 Company News Report on the Nitto ATP Finals Charity Programs Mon, 27 Jan 2020 09:00:00 +0800 Company News Establishment of the Tokyo Head Office and Consolidation with the Tokyo Sales Branch Tue, 03 Dec 2019 15:00:00 +0800 Company News Alliance with Drug Discovery Gateway Investment Limited Partnership to Accelerate the Commercialization of the New Transdermal Therapeutic System (“PassPort System”) Fri, 19 Jul 2019 12:00:00 +0800 Company News Sumitomo Dainippon Pharma and Nitto Denko Announce the Approval of Atypical Antipsychotic LONASEN® Tape in Japan Tue, 18 Jun 2019 15:00:00 +0800 Company News Launch of Bisono® Tape 2mg, a Transdermal Patch Containing a β1 Blocker Fri, 07 Jun 2019 15:00:00 +0800 Company News Established a Collaborative Research Department for the Development of New Nucleic Acid Drugs Nitto Denko and Osaka International Cancer Institute Thu, 18 Apr 2019 16:00:00 +0800 Company News The Nitto ATP Finals charitable activities in support of UNICEF Wed, 27 Feb 2019 09:00:00 +0800 Company News Nitto Named One of 2018-19 Derwent Top 100 Global Innovators, Marking its Eighth Consecutive Year on the List Wed, 23 Jan 2019 15:00:00 +0800 Company News Additional Approvals for Bisono®Tape, a Transdermal Patch containing a β1Blocker, for Atrial Fibrillation, for a 2 mg strength and for improved formulations of 4 mg and 8 mg strengths in Japan Tue, 08 Jan 2019 15:00:00 +0800 Company News Report on the Nitto ATP Finals Charity Programs Fri, 21 Dec 2018 15:00:00 +0800 Company News Nitto announces Phase I clinical trial of NBF-006 for the treatment of KRAS driven tumors in advanced cancer patients is allowed to proceed by the FDA Thu, 29 Nov 2018 09:00:00 +0800 Company News 100th anniversary greetings Thu, 25 Oct 2018 08:00:00 +0800 Company News Nitto Supports Reconstruction from the 2018 Hokkaido Eastern Iburi earthquake Fri, 28 Sep 2018 16:00:00 +0800 Company News New Drug Application in Japan for Transdermal Patch Formulation of Atypical Antipsychotic LONASEN® Tue, 31 Jul 2018 14:00:00 +0800 Company News About support for damage of the torrential rains Fri, 20 Jul 2018 17:00:00 +0800 Company News Onomichi Plant resumed operation Wed, 18 Jul 2018 14:48:40 +0800 Company News Effects of the Torrential Rains in July 2018 (2nd report) Sun, 15 Jul 2018 14:48:40 +0800 Company News Effects of the Torrential Rains in July 2018 Mon, 09 Jul 2018 18:13:42 +0800 Company News Nitto’s RO membrane to be used for Singapore’s first dual-mode desalination plant Thu, 21 Jun 2018 10:00:00 +0800 Company News Contributing to the Efficient Use of Limited Resources: New Nanofiltration Elements for Oil Field Water Injection (World’s Largest Membrane Area & Flow Rate) Thu, 31 May 2018 10:00:00 +0800 Company News Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator Accelerate Innovations in Life Science Tue, 15 May 2018 09:00:00 +0800 Company News Initiatives for an Environmentally Friendly Recycling-Oriented Green Plant Wed, 11 Apr 2018 10:00:00 +0800 Company News IND application of ND-L02-s0201 allowed to proceed for idiopathic pulmonary fibrosis indication by the FDA Development of ND-L02-s0201 for fibrosis Mon, 05 Mar 2018 15:00:00 +0800 Product Announcements Nitto Selected as Top 100 Global IP/Patents-Related Innovators for Seven Years in a Row 2017 Top 100 Global Innovators Award Thu, 25 Jan 2018 14:00:00 +0800 Company News A Word of Thanks for your Support to the Nitto ATP Finals and Report on Nitto’s Charity Program Wed, 27 Dec 2017 13:00:00 +0800 Company News New ads linked to Nitto ATP Finals placed in UK and Japan Thu, 09 Nov 2017 09:00:00 +0800 Company News Technical Partnership with the Hangzhou Jinjiang Group for Large-Scale Polarizing Film Thu, 02 Nov 2017 14:00:00 +0800 Company News New Promotion Movie “Behind Smiles (London Production)" Released Achieving global branding through smiling faces and the Nitto technology and products behind them Tue, 31 Oct 2017 13:00:00 +0800 Company News Joint Development of the World's First*2 Wireless Charging System for Hearing Instruments Using a Rechargeable Battery*1 Interchangeable with the Common Hearing Instrument Battery Thu, 12 Oct 2017 11:00:00 +0800 Company News Nitto Enters the New Plastic Optical Cable Business Transforming High-speed, Large-capacity Communications in the Era of Next-generation, High-definition Displays Tue, 26 Sep 2017 10:00:00 +0800 Company News Manufacturing Capacity Expansion for Oligonucleotide Active Pharmaceutical Ingredients in US Providing Increased Value to Customers in the Oligonucleotide Market Thu, 20 Jul 2017 13:00:00 +0800 Company News Nitto, the First Japanese Title Sponsor for the ATP Finals ~ Nitto Aiming for Global Brand Promotion and to Accelerate Innovation ~ Thu, 25 May 2017 19:00:00 +0800 Company News Nitto Awarded the “Prime Minister’s Prize” at the 2017 National Commendation for Invention -Prize awarded for contributing to thinner, more flexible displays by inventing an innovative method for manufacturing ultra-thin polarizing film- Thu, 25 May 2017 09:00:00 +0800 Company News “HARU stuck-on design;” wins the 2017 Red Dot Award for Product Design Tue, 11 Apr 2017 13:00:00 +0800 Company News “2016 Top 100 Global Innovators” Awards Ceremony Mon, 27 Mar 2017 00:00:00 +0800 Company News Nitto Named One of the 2016 Top 100 Global IP/Patents-related Innovators, Marking its Sixth Consecutive Year on the List Wed, 11 Jan 2017 10:00:00 +0800 Company News Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH Fri, 11 Nov 2016 18:10:34 +0800 Company News Initiation of Phase I Clinical Trial for Seasonal Influenza HA Vaccine Sublingual Tablet Building of the Innovative Platform for Vaccine Formulation Wed, 02 Nov 2016 09:00:00 +0800 Company News Nitto Denko Avecia Inc. Acquires Assets of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals Further Expansion of Therapeutic Oligonucleotide Business Wed, 12 Oct 2016 09:00:00 +0800 Company News Establishment of the Basic Procurement Policy and CSR-Based Procurement Guidelines Tue, 20 Sep 2016 09:00:00 +0800 Company News inovas, Integrating R&D and Human Resource Development, Receives 29th Nikkei New Office Award’s “New Office Promotion Award” and “Kinki New Office Promotion Award” Mon, 05 Sep 2016 13:00:00 +0800 Company News Regarding Power Receiving System Failure at Onomichi Plant Tue, 02 Aug 2016 15:30:00 +0800 Company News Acquisition of Functional Film for Curtain Airbags Business from Swiss Company Nolax Mon, 25 Jul 2016 14:05:17 +0800 Company News Initiation of Drug Development for Oncology Using Nitto’s Proprietary DDS Platform Mon, 11 Jul 2016 09:00:00 +0800 Company News A New Nitoms to Offer Comfort and Pleasure Merger of Nitto Group Companies, Nitoms, Nitto Medical, and Nitto Lifetec Fri, 01 Jul 2016 15:00:00 +0800 Company News Nitto Held a Company Information Meeting for Institutional Investors and Analysts Explained Mid-term Management Plan and Future Plans Mon, 20 Jun 2016 15:00:00 +0800 Company News Large-scale Investment in Manufacturing Facility for Ultra-Thin Polarizer in Shenzen, China Nitto's First Front End Manufacturing Facility for Polarizing Film in China Mon, 20 Jun 2016 09:00:00 +0800 Company News Institutional Investor “2016 All-Japan Executive Team Rankings” Nitto Selected in “Best CEOs” and Two Other Categories Wed, 15 Jun 2016 15:00:00 +0800 Company News Nitto Wins SID Display Component of the Year Award Thu, 19 May 2016 13:00:00 +0800 Company News Nitto Signs Partnership Agreement with Daiichi Sankyo: Accelerates the Commercialization of Nitto’s Active Transdermal Drug Delivery Technology “PassPort™ System” Tue, 10 May 2016 13:00:00 +0800 Product Announcements Nitto Supports Reconstruction from the 2016 Kumamoto Earthquake Thu, 21 Apr 2016 15:00:00 +0800 Company News Nitto establishes "inovas," a facility that fuses R&D with Human Resource Development Encouraging co-creation through a convergence of people, technology, and knowledge Tue, 15 Mar 2016 15:00:00 +0800 Company News Establishment of Nitto BioPharma, Inc. Mon, 25 Jan 2016 09:00:00 +0800 Company News Thomson Reuters 2015 Top 100 Global Innovators Awards Ceremony Mon, 04 Jan 2016 15:00:00 +0800 Company News Nitto’s ND-L02-s0201, RNAi Anti-Fibrosis Drug for the Treatment of Liver Fibrosis Granted FDA Fast Track Designation Fri, 20 Nov 2015 15:00:00 +0800 Product Announcements Nitto selected as one of the top 100 global companies in intellectual property and patents for the 5th consecutive year Thomson Reuters 2015 Top 100 Global Innovators Thu, 12 Nov 2015 15:00:00 +0800 Company News Nitto opens its Innovation Center in Shinagawa to create innovation with its customers Mon, 02 Nov 2015 09:00:00 +0800 Company News Nitto Innovation Museum to be Opened in Osaka Featuring a Giant COLOCOLO Packed with Innovation! Wed, 14 Oct 2015 15:00:00 +0800 Company News Nitto Innovation Museum to be Opened in Tokyo Featuring a Giant COLOCOLO Packed with Innovation! Fri, 09 Oct 2015 13:00:00 +0800 Company News World's First Magnetic Field Orientation Controlling Neodymium Magnet Mon, 24 Aug 2015 17:00:00 +0800 Product Announcements Relocation of the Tokyo Office and Launch of the Global Marketing Center Thu, 30 Jul 2015 13:00:00 +0800 Company News Automotive Electronics Site Established in Munich, Germany Fri, 24 Jul 2015 12:55:10 +0800 Company News Nitto Supports Nepal Earthquake Fri, 29 May 2015 12:55:10 +0800 Company News Novel Anti-fibrosis Drug with Molecular Targeting DDS Starts Phase-1b Dosing for Liver Fibrosis Patients in Japan Thu, 28 May 2015 12:55:10 +0800 Company News New facility to be named “inovas” A decision in the in-house contest to name new integrated R&D/human resources facility Wed, 20 May 2015 11:31:30 +0800 Company News A new plant in Taiwan to produce PVC tape for automotive wire harness bundling In response to growing demands from the shift towards lightweight cars with electronics, Tue, 12 May 2015 09:16:18 +0800 Company News The Nitto Channel opens on YouTube featuring our new TV commercials for the Osaka Women’s Marathon 2015 Wed, 21 Jan 2015 10:11:51 +0800 Company News Nitto chosen among the world’s top 100 intellectual property- and patent-related companies for the 4th straight year Thomson Reuters’ “Top 100 Global Innovators 2014” Thu, 25 Dec 2014 10:09:28 +0800 Company News Athletic Tape at Standard Chartered Singapore Marathon 2014 race pack collection event Wed, 17 Dec 2014 10:01:30 +0800 Company News New Anti-fibrosis Drug with Molecular Targeting DDS Starts Phase-1b Dosing for Cirrhosis Patients Mon, 06 Oct 2014 07:00:00 +0800 Company News Establishment of a facility for integrated R&D and human resource development activities Aiming at realizing co-creation through encounters of people, knowledge and technology Wed, 17 Sep 2014 19:37:58 +0800 Company News R&D center to be established inside Qingdao Industrial Technology Research Institute, our first in China Accelerating the creation of new themes in China Wed, 10 Sep 2014 19:32:04 +0800 Company News Automotive Technical Center Upgrade Contributing to the future of vehicles through innovations in the integration of materials and evaluation technologies Wed, 30 Jul 2014 11:51:14 +0800 Company News New Anti-fibrosis Drug with Molecular Targeting DDS Completed Phase-1a Dose Escalation Tue, 22 Apr 2014 10:00:00 +0800 Product Announcements Newly Launched PV Encapsulating Sheets with Wavelength Conversion Technology Power Enhancement of PV Modules by Utilizing UV Light in Sunlight Sun, 23 Feb 2014 17:13:23 +0800 Product Announcements Change of Representative Directors Fri, 31 Jan 2014 18:55:57 +0800 Company News Nitto Supports Philippines Typhoon Victims Thu, 12 Dec 2013 13:34:58 +0800 Company News Nitto Selected as Top 100 Global IP/Patents-Related Innovators for Three Years in a Row Thomson Reuters 2013 Top 100 Global Innovators Award Mon, 11 Nov 2013 18:53:57 +0800 Company News Nitto Opens an Innovation Company in Silicon Valley, California Focusing on business development in new business domains Mon, 28 Oct 2013 10:00:00 +0800 Company News Relaunch of Our Global Website Tue, 01 Oct 2013 00:00:00 +0800 Company News Nitto Denko Group Branding Reform Mon, 19 Aug 2013 19:01:09 +0800 Company News World’s First Transdermal β₁-Blocker Patch Developed to Contribute to Treatment of Hypertention Patients Toa Eiyo Obtains Marketing Authorization for Bisono® tape in Japan Fri, 28 Jun 2013 15:00:00 +0800 Product Announcements “Pain Relief in Laser Irradiation Treatment of the Skin” Approved as an Additional Indication for Penles® Tape 18 mg, a Local Anesthetic Patch Preparation Fri, 14 Jun 2013 21:48:14 +0800 Product Announcements Nitto Denko announces development of MARINGLIDE antiffouling protection film for marine applications Company continues development of highly functional and econ-friendly products Thu, 28 Feb 2013 22:28:50 +0800 Product Announcements Nitto Denko develops a new thermosetting thermal resistant encapsulation sheet for LED Fri, 15 Feb 2013 09:07:19 +0800 Product Announcements Nitto Denko announces release of PENJEREX™-Transparent Energy-Saving Window Insulation Film Company enters new business in environmental field with the industry's leading thermal insulation film Thu, 29 Nov 2012 15:15:51 +0800 Product Announcements Nitto Denko Signs Agreement to Acquire the Business of Girindus America, Inc. Boosting Business Growth Further in the Therapeutic Oligonucleotide Segment Tue, 13 Nov 2012 15:08:10 +0800 Company News Nitto Denko to open new manufacturing plant in Brazil Company continues progressive international expansion Thu, 18 Oct 2012 15:05:12 +0800 Company News Nitto Denko named to Dow Jones Sustainability Index Company’s sustainability initiatives recognized for first time Mon, 24 Sep 2012 14:56:15 +0800 Company News Phase 2 studies start on the world’s first transdermal patch formulation for schizophrenia treatment Nitto Denko and Dainippon Sumitomo Pharma Joint Development Fri, 27 Jul 2012 12:47:44 +0800 Company News Nitto Denko to launch R&D centre in Switzerland to focus on environmental and life science-related materials innovation Accelerating creative endeavors in Europe Fri, 20 Jul 2012 12:43:39 +0800 Company News Nitto Shinko establishes new subsidiary in China Company to aggressively pursue Chinese market Sat, 26 May 2012 10:14:31 +0800 Company News Nitto Denko obtains US patent for antifibrotic therapies with molecular targeting DDS technology Company targets clinical trial of antifibrotic drug in 2013 Thu, 10 May 2012 10:11:26 +0800 Product Announcements Nitto Denko acquires all assets of Altea Therapeutics Nitto Denko to expand transdermal patch product lineup Wed, 25 Apr 2012 10:07:08 +0800 Company News Nitto Denko acquires Turkey’s No.1 tape maker Bento Achieving the local-optimal business setup in emerging markets Wed, 18 Apr 2012 10:00:59 +0800 Company News Nitto Denko launches Solution Center Hands-on customer interfacing facility to create new demand and pursue innovation in cooperation with customers Thu, 05 Apr 2012 09:39:34 +0800 Company News Nitto Denko receives the Thomson Reuters Top 100 Global Innovator Award Fri, 16 Dec 2011 10:42:04 +0800 Company News